| Identification | Back Directory | [Name]
17-TRANS PROSTAGLANDIN E3 | [CAS]
210979-33-2 | [Synonyms]
17-TRANS PROSTAGLANDIN E3
CBOMORHDRONZRN-YYFRSVFISA-N
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17E-TRIEN-1-OIC ACID
Prosta-5,13,17-trien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S,17E)- (9CI) | [Molecular Formula]
C20H30O5 | [MDL Number]
MFCD00216059 | [MOL File]
210979-33-2.mol | [Molecular Weight]
350.45 |
| Chemical Properties | Back Directory | [solubility ]
DMF: >100 mg/ml (from PGE2); DMSO: >100 mg/ml (from PGE2); Ethanol: >100 mg/ml (from PGE2); PBS pH 7.2: >5 mg/ml (from PGE2) |
| Hazard Information | Back Directory | [Description]
17-trans PGE3 is an isomer of PGE3 which could theoretically result from the COX metabolism of dietary trans-fatty acids. There are no published reports on the biological activity of this compound. | [Uses]
17-trans Prostaglandin E3 is a prostaglandin analog, and stimulates Nurr1-dependent transcriptional activity. 17-trans Prostaglandin E3 can be used for research of condition associated with Nurr1,such as cancer and autoimmune disease[1]. | [References]
[1] Cheolhwan Yoon, et al. Prostaglandin analogs and uses thereof. Patent. US20210139435. |
|
|